Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2019

Dec 11, 2019

30198_dirs_2019-12-10_d790fc67-2837-4459-8ec4-dddb5cb13926.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-12-09

Reporting Person: Murphy Patrick Michael (SVP, Legal Affairs)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-09 Common Stock S 1900 $223.3139 Disposed 31065 Direct
2019-12-09 Common Stock S 1999 $224.36 Disposed 29066 Direct
2019-12-09 Common Stock S 1219 $225.5539 Disposed 27847 Direct
2019-12-09 Common Stock S 400 $226.51 Disposed 27447 Direct

Footnotes

F1: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $223.01 to $224.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020.

F4: This transaction was executed in multiple trades at prices ranging from $224.01 to $225.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $225.05 to $226.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $226.07 to $226.88. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.